Boric Acid

Boric Acid

SCHEMBL6516482

Fc1cc(F)c(-c2c(F)cc(F)c(F)c2F)c(F)c1F.Fc1cc(F)c(-c2c(F)cc(F)c(F)c2F)c(F)c1F.Fc1cc(F)c(-c2c(F)cc(F)c(F)c2F)c(F)c1F.OB(O)O

nearest known ligand 0.37

Full drug profile on Sugi Atlas →

Predicted protein targets (top 10)

geneUniProtsupporting neighboursconfidence
CA1 P00915 3/20 0.37
CA2 P00918 3/20 0.37
CA4 P22748 2/20 0.37
CES2 O00748 2/20 0.35
CES1 P23141 2/20 0.35
CA12 O43570 1/20 0.32
CA7 P43166 1/20 0.32
CA13 Q8N1Q1 1/20 0.32
ESR1 P03372 1/20 0.30
ESR2 Q92731 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5043154 0.88 CA1 (0.38) CA1CA2CA4CES2CES1
SCHEMBL5084618 0.85 CA1 (0.36) CA1CA2CA4CES2CES1
SCHEMBL31711779 0.85 CA1 (0.36) CA1CA2CA4CES2CES1
Boric Acid SCHEMBL6747361 0.85 CA1 (0.42) CA1CA2CA4CES2CES1
Boric Acid SCHEMBL27413055 0.85 CA1 (0.42) CA1CA2CA4CES2CES1
Boric Acid SCHEMBL31146818 0.82 CA1 (0.40) CA1CA2CA4CES2CES1
Boric Acid SCHEMBL29061946 0.82 CA1 (0.40) CA1CA2CA4CES2CES1
SCHEMBL4601549 0.82 CA1 (0.35) CA1CA2CA4CES2CES1
Boric Acid SCHEMBL6515450 0.82 CA1 (0.40) CA1CA2CA4CES2CES1
SCHEMBL31711757 0.80 CA1 (0.33) CA1CA2CA4CES2CES1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6861384-B2 Process for preparation of a salt-like chemical compound and its use in catalyst systems for preparing polyolefins BASELL POLYOLEFINE GMBH (DE) 2005-03-01 US disclosed
US-20040072975-A1 Salt-like chemical compound, its preparation and its use in catalyst systems for preparing polyolefins BASELL POLYPROPYLEN GMBH (DE) 2004-04-15 US disclosed
US-20040048992-A1 Process for preparation of salt-like chemical compound, and its use in catalyst systems for preparing polyolefins EQUISTAR CHEMICALS, LP 2004-03-11 US disclosed
US-20030069426-A1 Saline chemical composition, method for producing the same and the use thereof in catalyst systems for producing polyolefins SCHOTTEK JORG (DE) 2003-04-10 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030069426-A1 Saline chemical composition, method for producing the same and the use thereof in catalyst systems for producing polyolefins CLIC1, HACL2, ADH1C CA1 349/4885CA2 170/4885CA4 611/4885
US-20040048992-A1 Process for preparation of salt-like chemical compound, and its use in catalyst systems for preparing polyolefins CLIC1, HACL2, RFC1 CA1 587/4885CA2 129/4885CA4 175/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.